Company Quick10K Filing
True Nature Holding
Closing Price ($) Shares Out (MM) Market Cap ($MM)
$0.00 39 $4
10-Q 2019-11-14 Quarter: 2019-09-30
10-Q 2019-08-14 Quarter: 2019-06-30
10-Q 2019-05-20 Quarter: 2019-03-31
10-K 2019-04-01 Annual: 2018-12-31
10-Q 2018-11-14 Quarter: 2018-09-30
10-Q 2018-08-14 Quarter: 2018-06-30
10-Q 2018-06-04 Quarter: 2018-03-31
10-K 2018-04-17 Annual: 2017-12-31
10-Q 2017-12-05 Quarter: 2017-09-30
10-Q 2017-08-18 Quarter: 2017-06-30
10-Q 2017-05-15 Quarter: 2017-03-31
10-K 2017-04-17 Annual: 2016-12-31
10-Q 2016-12-14 Quarter: 2016-09-30
10-Q 2016-08-09 Quarter: 2016-06-30
10-Q 2016-05-20 Quarter: 2016-03-31
10-K 2016-05-02 Annual: 2015-12-31
10-Q 2015-12-08 Quarter: 2015-09-30
10-Q 2015-08-14 Quarter: 2015-06-30
10-Q 2015-05-20 Quarter: 2015-03-31
10-K 2015-04-15 Annual: 2014-12-31
10-Q 2014-11-25 Quarter: 2014-09-30
10-Q 2014-08-19 Quarter: 2014-06-30
10-Q 2014-05-20 Quarter: 2014-03-31
10-K 2014-04-15 Annual: 2013-12-31
10-Q 2013-11-18 Quarter: 2013-09-30
10-Q 2013-08-14 Quarter: 2013-06-30
10-Q 2013-05-20 Quarter: 2013-03-31
10-K 2013-04-16 Annual: 2012-12-31
10-Q 2012-11-19 Quarter: 2012-09-30
10-Q 2012-08-20 Quarter: 2012-06-30
10-Q 2012-05-21 Quarter: 2012-03-31
10-Q 2012-02-21 Quarter: 2011-12-31
10-Q 2011-11-14 Quarter: 2011-09-30
10-K 2011-10-13 Annual: 2011-06-30
10-Q 2011-05-16 Quarter: 2011-03-31
10-Q 2011-02-14 Quarter: 2010-12-31
10-Q 2010-11-15 Quarter: 2010-09-30
10-K 2010-09-28 Annual: 2010-06-30
10-Q 2010-05-17 Quarter: 2010-03-31
10-Q 2010-02-16 Quarter: 2009-12-31
8-K 2020-01-27 Enter Agreement, Off-BS Arrangement, Sale of Shares, Amend Bylaw, Exhibits
8-K 2020-01-21 Officers, Regulation FD, Other Events, Exhibits
8-K 2019-12-19 Enter Agreement, Leave Agreement, Sale of Shares, Control, Officers, Regulation FD, Exhibits
8-K 2019-11-11 Leave Agreement, Enter Agreement, Off-BS Arrangement, Sale of Shares, Exhibits
8-K 2019-09-11 Regulation FD, Exhibits
8-K 2019-08-20 Regulation FD, Exhibits
8-K 2019-08-15 Enter Agreement, Sale of Shares, Exhibits
8-K 2019-07-02 Enter Agreement, Off-BS Arrangement, Sale of Shares, Exhibits
8-K 2019-05-01 Enter Agreement, Off-BS Arrangement, Sale of Shares, Exhibits
8-K 2019-04-24 Enter Agreement, Off-BS Arrangement, Sale of Shares, Officers, Other Events, Exhibits
8-K 2019-03-18 Regulation FD, Exhibits
8-K 2019-03-18 Enter Agreement, Off-BS Arrangement, Sale of Shares, Exhibits
8-K 2019-02-11 Enter Agreement, Off-BS Arrangement, Sale of Shares, Officers, Exhibits
8-K 2018-11-26 Enter Agreement, Sale of Shares, Officers, Regulation FD, Exhibits
8-K 2018-11-26
8-K 2018-10-17 Officers, Sale of Shares, Regulation FD, Other Events, Exhibits
8-K 2018-09-28 Officers, Regulation FD, Sale of Shares, Other Events, Exhibits
8-K 2018-08-09 Sale of Shares, Regulation FD, Other Events, Exhibits
8-K 2018-08-09 Enter Agreement, Leave Agreement, Sale of Shares, Officers, Regulation FD, Other Events, Exhibits
8-K 2018-08-09 Enter Agreement, Off-BS Arrangement, Sale of Shares, Regulation FD, Other Events, Exhibits
8-K 2018-07-05 Enter Agreement, Off-BS Arrangement, Sale of Shares, Officers, Regulation FD, Exhibits
8-K 2018-06-27 Enter Agreement, Sale of Shares, Regulation FD, Exhibits
8-K 2018-04-05 Enter Agreement, Regulation FD, Exhibits

True Nature Holding Financials

TNTY Metrics, Comps, Filings

Annual | Quarterly

Business

True Nature Holding, Inc. (the “Company,” “we,” “us,” or “our”), previously known as Trunity Holdings, Inc., a Delaware corporation, became a publicly-traded company through a reverse triangular merger with Brain Tree International, Inc., a Utah corporation (“BTI”). Trunity Holdings, Inc. was the parent company of our educational business, named Trunity, Inc., which was formed on July 28, 2009 through the acquisition of certain intellectual property from its three founders. On December 9, 2015 the Company made a decision to restructure Trunity Holdings, Inc., having acquired Newco4pharmacy, LLC, a development stage business aimed at a roll-up of compounding pharmacy businesses. As a part of such restructuring, we competed a “spin out” transaction of our educational business line to our shareholders as of December 31, 2015.

Our business during 2018 was focused in the area of software and solutions, predominantly in the healthcare sector, generally described as the healthcare information and technology (HCIT) market. We announced plans for a personal healthcare records (PHR) application, SimpleHIPAA, which will allow individuals to track their personal healthcare information. This type of application is intended to include information from the individual, as well as data from healthcare providers extracted from their electronic healthcare records (EHR) systems. Data from individuals might include manual input or from personal devices such as watches, activity trackers and diagnostic devices such as glucose meters or blood pressure measuring devices. Information from healthcare providers might include data gathered from regular doctor visits, specialized care, or even a simple as prescription information from a pharmacy.

Our initial implementation of “SimpleHIPAA”, and “SimpleHIPAA for Vets and Pets”, is intended to include data from pharmacy and prescribers, generated at the time a prescription is written. This information will be embedded inside the application and made available to the end user from both the healthcare provider and from the pharmacy. While providing a starting point for tracking healthcare information for the end user, it also establishes a communications method between the end user and the healthcare provider, and the pharmacy. This communications channel, often thought of as “telemedicine” can allow the end user to provide feedback to the healthcare provider, the pharmacy, or other parties of the end user's choice.


Valuation ($MM)

Market Cap, Enterprise Value

Balance Sheet ($MM)

Assets, Stockholders' Equity

Income Statement ($MM Annual)

Revenue, Gross Profit, Net Income

Cash Flow ($MM Annual)

Operating, Investing, Financing

Comps ($'000 TTM) Market Cap Gross Margin EV/EBITDA Ret on Assets Assets Liabilities Revenue G Profit Net Income EBITDA EV
Brightlane (BTLN) 4,486 79% -12.6 35,295,700% 100 79 -353 -353 4,449
Amplitech (AMPG) 4,468 54% 10.1 19% 1,810 717 2,660 1,447 342 415 4,190
Inception Mining (IMII) 4,468 -0.5 -727% 1,308 23,908 0 0 -9,511 -9,429 4,455
STR Holdings (STRI) 4,433 -36% -0.5 -37% 22,829 6,387 8,136 -2,910 -8,438 -9,407 4,738
Rodin Income Trust (RIT) 4,428 13.9 1% 25,840 17,277 0 0 298 298 4,133
Legacy Education Alliance (LEAI) 4,401 14% 0.9 -26% 27,535 76,570 90,706 12,769 -7,064 -6,234 -5,736
Artemis Therapeutics (ATMS) 4,380 -17.4 -661% 38 254 0 0 -251 -251 4,373
Globe Photos (GBPT) 4,374 4% -0.7 -33% 21,078 15,658 5,514 234 -6,876 -6,259 4,101
Greenkraft (GKIT) 4,344 50% -112.9 -2% 2,619 4,942 958 478 -39 -39 4,452
OWC Pharmaceutical Research (OWCP) 4,325 0% 3.9 27% 2,335 1,750 100 0 636 636 2,485
First Foods Group (FIFG) 4,309 0% -2.1 -479% 432 1,464 439 0 -2,070 -2,045 4,276
Wize Pharma (WIZP) 4,304 -0% -0.8 -115% 2,599 2,134 -2 0 -2,981 -2,981 2,509
True Nature Holding (TNTY) 4,298 -2.7 -701,080% 0 1,851 0 0 -1,991 -1,616 4,298
Apricus Biosciences (APRI) 4,255 0.1 -409% 10,279 5,340 0 0 -42,069 -42,051 -5,473
ICTV Brands (ICTV) 4,251 69% -1.0 -52% 11,670 9,605 29,768 20,607 -6,058 -4,863 4,958
IIoT-OXYS (ITOX) 4,225 46% -2.4 -505% 445 2,056 225 103 -2,251 -2,006 4,837
Thunder Mountain Gold (THMG) 4,210 0% 4.2 41% 2,340 1,720 1,554 0 971 971 4,059
Cleartronic (CLRI) 4,208 76% -19.8 -111% 248 1,528 946 714 -275 -211 4,177
Alliance Bioenergy Plus (ALLM) 4,195 -0.4 -217% 4,404 4,162 0 0 -9,552 -9,481 4,191
Sport Endurance (SENZ) 4,142 -2.3 -66% 2,349 2,746 0 0 -1,549 -1,788 4,034

Balance Sheet ($'000)2012-12-312013-12-312014-12-312015-12-312016-12-312017-12-312018-12-31
Cash14812142801
Accounts Receivable233
Inventory
PP&E5321020
Assets7791,65196545204
Accounts Payable619394985414766794
Long-Term Debt045
Liabilities1,6831,9843,2295651,0681,3871,658
Stockholders' Equity-903-333-2,264-520-1,066-1,387-1,654
Income Statement ($'000)2012-12-312013-12-312014-12-312015-12-312016-12-312017-12-312018-12-31
Revenue159176228000
Cost of Revenue59781730
Gross Profit10198550
R&D8948398920
SG&A1,4932,2682,235654,4057001,316
Tax000
Net Income-2,428-3,402-3,770-403-4,881-754-1,415
Cash Flow ($'000)2012-12-312013-12-312014-12-312015-12-312016-12-312017-12-312018-12-31
Cash Operating-1,448-2,109-1,444-79-270-47-247
Cash Investing-564-562-59100
Cash Financing1,9033,4691,23810724147248